venBio Select Advisor LLC Buys Loxo Oncology Inc, Sarepta Therapeutics Inc, Amarin Corp PLC, Sells Endocyte Inc, Puma Biotechnology Inc, Madrigal Pharmaceuticals Inc

• New Purchases: LOXO, PTI,
• Added Positions: SRPT, AMRN, ZGNX, IOVA, ARGX, FOLD, GBT, TGTX, FENC, XENE,
• Reduced Positions: MDGL, PTCT, ACER, HZNP, ASMB, BDSI, PCRX, TCDA, NTEC,
• Sold Out: ECYT, PBYI, CLVS, CPRX, ARWR, SESN, VNDA, CRSP, TSRO, ACAD, DBVT, ONCS, PRNB,

For the details of venBio Select Advisor LLC's stock buys and sells, go to https://www.gurufocus.com/guru/venbio+select+advisor+llc/current-portfolio/portfolio

1. Immunomedics Inc (IMMU) - 17,714,461 shares, 15.45% of the total portfolio.
2. Mirati Therapeutics Inc (MRTX) - 4,798,101 shares, 12.44% of the total portfolio.
3. Sarepta Therapeutics Inc (SRPT) - 1,275,000 shares, 8.51% of the total portfolio. Shares added by 35.14%
4. Ascendis Pharma A/S (ASND) - 1,980,000 shares, 7.58% of the total portfolio. Shares added by 0.85%
5. Biomarin Pharmaceutical Inc (BMRN) - 1,360,000 shares, 7.08% of the total portfolio. Shares reduced by 0.59%

venBio Select Advisor LLC initiated holding in Loxo Oncology Inc. The purchase prices were between $127.8 and $176.35, with an estimated average price of $150.91. The stock is now traded at around $234.66. The impact to a portfolio due to this purchase was 2.78%. The holding were 325,000 shares as of .

venBio Select Advisor LLC initiated holding in Proteostasis Therapeutics Inc. The purchase prices were between $1.75 and $10.35, with an estimated average price of $4.87. The stock is now traded at around $4.33. The impact to a portfolio due to this purchase was 0.26%. The holding were 1,300,000 shares as of .

venBio Select Advisor LLC added to a holding in Sarepta Therapeutics Inc by 35.14%. The purchase prices were between $97.32 and $147.38, with an estimated average price of $124.11. The stock is now traded at around $123.85. The impact to a portfolio due to this purchase was 2.21%. The holding were 1,275,000 shares as of .

venBio Select Advisor LLC added to a holding in Amarin Corp PLC by 37.82%. The purchase prices were between $12.41 and $22.98, with an estimated average price of $18.17. The stock is now traded at around $19.01. The impact to a portfolio due to this purchase was 1.27%. The holding were 5,575,000 shares as of .

venBio Select Advisor LLC added to a holding in Zogenix Inc by 35.47%. The purchase prices were between $34.16 and $44.66, with an estimated average price of $40.82. The stock is now traded at around $52.42. The impact to a portfolio due to this purchase was 1.15%. The holding were 1,975,000 shares as of .

venBio Select Advisor LLC added to a holding in Global Blood Therapeutics Inc by 21.74%. The purchase prices were between $31.54 and $46.67, with an estimated average price of $37.55. The stock is now traded at around $51.15. The impact to a portfolio due to this purchase was 0.16%. The holding were 350,000 shares as of .

venBio Select Advisor LLC sold out a holding in Endocyte Inc. The sale prices were between $14.93 and $24, with an estimated average price of $22.16.

venBio Select Advisor LLC sold out a holding in Puma Biotechnology Inc. The sale prices were between $20.07 and $46.7, with an estimated average price of $29.42.

venBio Select Advisor LLC sold out a holding in Clovis Oncology Inc. The sale prices were between $11.63 and $32.67, with an estimated average price of $20.2.

venBio Select Advisor LLC sold out a holding in Catalyst Pharmaceuticals Inc. The sale prices were between $1.92 and $3.58, with an estimated average price of $2.83.

venBio Select Advisor LLC sold out a holding in Arrowhead Pharmaceuticals Inc. The sale prices were between $10.74 and $19.7, with an estimated average price of $13.53.

venBio Select Advisor LLC sold out a holding in Sesen Bio Inc. The sale prices were between $0.96 and $2.04, with an estimated average price of $1.58.

venBio Select Advisor LLC reduced to a holding in Madrigal Pharmaceuticals Inc by 51.4%. The sale prices were between $94.77 and $215.54, with an estimated average price of $151.78. The stock is now traded at around $140.09. The impact to a portfolio due to this sale was -2.42%. venBio Select Advisor LLC still held 225,000 shares as of .

venBio Select Advisor LLC reduced to a holding in PTC Therapeutics Inc by 44.44%. The sale prices were between $29.83 and $45.28, with an estimated average price of $35.64. The stock is now traded at around $37.77. The impact to a portfolio due to this sale was -0.68%. venBio Select Advisor LLC still held 380,000 shares as of .

venBio Select Advisor LLC reduced to a holding in Acer Therapeutics Inc by 46.43%. The sale prices were between $16.55 and $29.1, with an estimated average price of $22.82. The stock is now traded at around $23.75. The impact to a portfolio due to this sale was -0.19%. venBio Select Advisor LLC still held 150,000 shares as of .